Connection

Xing-Lou Yang to Betacoronavirus

This is a "connection" page, showing publications Xing-Lou Yang has written about Betacoronavirus.
Connection Strength

0.073
  1. Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture. Emerg Microbes Infect. 2020 Dec; 9(1):1170-1173.
    View in: PubMed
    Score: 0.010
  2. Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques. Cell Res. 2020 08; 30(8):670-677.
    View in: PubMed
    Score: 0.009
  3. Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2. Cell. 2020 07 09; 182(1):50-58.e8.
    View in: PubMed
    Score: 0.009
  4. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020 06; 582(7811):289-293.
    View in: PubMed
    Score: 0.009
  5. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020; 9(1):386-389.
    View in: PubMed
    Score: 0.009
  6. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 03; 30(3):269-271.
    View in: PubMed
    Score: 0.009
  7. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 03; 579(7798):270-273.
    View in: PubMed
    Score: 0.009
  8. Longitudinal Surveillance of Betacoronaviruses in Fruit Bats in Yunnan Province, China During 2009-2016. Virol Sin. 2018 Feb; 33(1):87-95.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.